SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.

Harris, Julie R; Owusu, Daniel; O'Laughlin, Kevin; Cohen, Adam L; Ben Hamida, Amen; Patel, Jaymin C; Freeman, Molly M; Nsibambi, Thomas; Nieves, Rebecca; Marston, Barbara J; Wasike, Samuel; Galbraith, Jennifer S; Boore, Amy L; Nelson, Lisa J; Guagliardo, Sarah Anne J; Klena, John D; Patel, Ketan; Ma, Marek

Harris, Julie R; Owusu, Daniel; O'Laughlin, Kevin; Cohen, Adam L; Ben Hamida, Amen; Patel, Jaymin C; Freeman, Molly M; Nsibambi, Thomas; Nieves, Rebecca; Marston, Barbara J; Wasike, Samuel; Galbraith, Jennifer S; Boore, Amy L; Nelson, Lisa J; Guagliardo, Sarah Anne J; Klena, John D; Patel, Ketan; Ma, Marek.

Emerg Infect Dis ; 28(6): 1279-1280, 2022 06.

Article in English | MEDLINE | ID: covidwho-1809304

ABSTRACT

ABSTRACT

The SARS-CoV-2 Delta variant emerged shortly after COVID-19 vaccines became available in 2021. We describe SARS-CoV-2 breakthrough infections in a highly vaccinated, well-monitored US Embassy community in Kampala, Uganda. Defining breakthrough infection rates in highly vaccinated populations can help determine public health messaging, guidance, and policy globally.

Subject(s)

COVID-19; SARS-CoV-2; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines; Humans; SARS-CoV-2/genetics; Uganda/epidemiology

Keywords

COVID-19; SARS; SARS-CoV-2; US Embassy; Uganda; breakthrough; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine; viruses; zoonoses

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Emerg Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google